Investment analysts at B. Riley issued their Q1 2025 earnings per share estimates for shares of biote in a research note ...

biote has a 52 week low of $4.03 and a 52 week ... optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote ...

Biote Corp. (BTMD) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.14 per share a year ago. These ...

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic ...

Biote Corp. (BTMD) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.14 per share a year ago. These figures ...